Larvol Delta - Wugen-to-Initiate-a-Pivotal-Trial-for-Its-Investigational-OfftheShelf-Allogeneic-CD7Targeted-CART-Cell-Therapy-WUCART007-in-Patients-with-Relapsed-or-Refractory-T-Cell-Acute-Lymphoblastic-Leukemia-or-T-Cell-Lymphoblastic-Lymphoma

WU CART 007 - Wugen

https://www.globenewswire.com/news-release/2024/11/12/2978872/0/en/Wugen-to-Initiate-a-Pivotal-Trial-for-Its-Investigational-Off-the-Shelf-Allogeneic-CD7-Targeted-CAR-T-Cell-Therapy-WU-CART-007-in-Patients-with-Relapsed-or-Refractory-T-Cell-Acute-.html

Nov 12, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next